Cited by 91Neuroinflammation and Neurodegeneration MechanismsHIV Research and TreatmentInfectious Diseases and Tuberculosis

LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein

Open access
Marker, Daniel F, Puccini, Jenna M, Mockus, Taryn E, Barbieri, Justin, Lu, Shao-Ming, Gelbard, Harris A·2012·Journal of Neuroinflammation

Abstract

BACKGROUND: Human Immunodeficiency Virus-1 (HIV-1) associated neurocognitive disorders (HANDs) are accompanied by significant morbidity, which persists despite the use of combined antiretroviral therapy (cART). While activated microglia play a role in pathogenesis, changes in their immune effector functions, including phagocytosis and proinflammatory signaling pathways, are not well understood. We have identified leucine-rich repeat kinase 2 (LRRK2) as a novel regulator of microglial phagocytosis and activation in an in vitro model of HANDs, and hypothesize that LRRK2 kinase inhibition will attenuate microglial activation during HANDs. METHODS: We treated BV-2 immortalized mouse microglia cells with the HIV-1 trans activator of transcription (Tat) protein in the absence or presence of LRRK2 kinase inhibitor (LRRK2i). We used Western blot, qRT-PCR, immunocytochemistry and latex bead engulfment assays to analyze LRRK2 protein levels, proinflammatory cytokine and phagocytosis receptor expression, LRRK2 cellular distribution and phagocytosis, respectively. Finally, we utilized ex vivo microfluidic chambers containing primary hippocampal neurons and BV-2 microglia cells to investigate microglial phagocytosis of neuronal axons. RESULTS: We found that Tat-treatment of BV-2 cells induced kinase activity associated phosphorylation of serine 935 on LRRK2 and caused the formation of cytoplasmic LRRK2 inclusions. LRRK2i decreased Tat-induced phosphorylation of serine 935 on LRRK2 and inhibited the formation of Tat-induced cytoplasmic LRRK2 inclusions. LRRK2i also decreased Tat-induced process extension in BV-2 cells. Furthermore, LRRK2i attenuated Tat-induced cytokine expression and latex bead engulfment. We examined relevant cellular targets in microfluidic chambers and found that Tat-treated BV-2 microglia cells cleared axonal arbor and engulfed neuronal elements, whereas saline treated controls did not. LRRK2i was found to protect axons in the presence of Tat-activated microglia, as well as AnnexinV, a phosphatidylserine-binding protein. In addition, LRRK2i decreased brain-specific angiogenesis inhibitor 1 (BAI1) receptor expression on BV-2 cells after Tat-treatment, a key receptor in phosphatidylserine-mediated phagocytosis. CONCLUSION: Taken together, these results implicate LRRK2 as a key player in microglial inflammation and, in particular, in the phagocytosis of neuronal elements. These studies show that LRRK2 kinase inhibition may prove an effective therapeutic strategy for HANDs, as well as other neuroinflammatory conditions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1742-2094-9-261

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Extracellular α-synuclein aggregates can interact with microglia via TLR2 to activate the LRRK2-NFATc2 pathway and produce a pro-inflammatory phenotype, and can also interact with other receptors to initiate LRRK2-dependent aggregate phagocytosis and clearance via lysosomal pathways.

    “Extracellular α-synuclein aggregates may interact with microglia in at least two different ways: on one hand, they may stimulate TLR2 to activate the LRRK2-NFATc2 pathway and produce a pro-inflammatory phenotype, as shown in the present study; on the other, they can also interact with other receptors to initiate LRRK2-dependent aggregate phagocytosis (48) and clearance via lysosomal pathways (49,”

    From LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies (2020) · cites this paper as [48]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Marker, D. F., Puccini, J. M., Mockus, T. E., Barbieri, J., Lu, S.-M., & Gelbard, H. A.
Affiliations
University of Rochester Medicine (US)
Corresponding author
  • Marker, Daniel F
  • Puccini, Jenna M
Venue
Journal of Neuroinflammation
Published
2012-11-29
Volume
9
Issue
1
Pages
261-261
ISSN
1742-2094 (ISSN-L)
OpenAlex
W2117667168
Cited by
90
References
61
Citations by year
2026: 3 · 2025: 2 · 2024: 6 · 2023: 7 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 9 · 2018: 11 · 2017: 7 · 2016: 9 · 2015: 8 · 2014: 7 · 2013: 7
FWCI
3.71
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institute of Mental Health (P01 MH 64570, F32MH099913, P01MH064570, R01 MH 56838, F30MH095664, R01MH056838)
  • National Institute of General Medical Sciences (T32GM007356)
  • National Institute of Allergy and Infectious Diseases (T32 AI 49815, T32AI049815, P30AI078498)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Surgery › Infectious Diseases and Tuberculosis
Keywords
LRRK2, HIV-1 Tat protein, microglial phagocytosis, HIV-associated neurocognitive disorders, LRRK2 kinase inhibition, microglial activation, inflammatory cytokines, microfluidic chamber
MeSH terms
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Analysis of Variance, Animals, Axons, Cell Line, Transformed, Cytoplasm, Enzyme Inhibitors, Hippocampus, Humans, Microspheres, Neurons, Phagocytosis, Phosphorylation, RNA, Messenger, Serine, HIV-1, Gene Expression Regulation, Viral, Cytokines, Annexin A5, Protein Serine-Threonine Kinases, Microglia, Coculture Techniques, CD11b Antigen, Microfluidic Analytical Techniques, Mice, tat Gene Products, Human Immunodeficiency Virus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review